SESSION X

THE ECONOMICS OF INTERVENTIONAL THERAPIES AND IMPLICATIONS FOR PUBLIC HEALTH
(3:15 – 4:30 pm)

Session Chair
Ara Darzi (UK)

Program Committee
David Flum (USA)
Desmond Johnston (UK)

Objectives
• To present and discuss a cost-effective analysis of surgery for diabetes
• To present and discuss the implications for public health and health care systems

Keynote Lectures
• Surgery for Diabetes: Implications and Challenges for Health Care Systems- Ara Darzi (UK)
Economics and Cost Effectiveness of Surgery for Diabetes- Pierre Cremieux (USA)

Panel Discussion
Diabetes Surgery: Barriers, Advantages, Cultural and Economic Implications and the Public Health Perspective

Moderators
TBD

Panelists
Ross Brechner- Centers for Medicare and Medicaid Services(USA)
David Flum- Surgeon, University of Washington (USA)
Louis Hochheiser- Clinical Policy Development, Humana Inc. (USA)
Richard Kahn- Chief Scientific Officer, ADA (USA)
Michael Minshall- Health Economics, IMS Health (USA)
Tracey Moorhead- CEO, Managed Care (USA)
Adrian Pollitt- Director of National Specialised Commissioning (NHS-UK)